Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

May 2021

Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 ...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander M M
Blank, Christian U
Mandalà, Mario
Long, Georgina V
Atkinson, Victoria G
et al
Dummer, Reinhard

May 2021

BACKGROUND The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-05...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.

Eggermont, AMM
Blank, CU
Mandala, M
Long, GV
Atkinson, VG
Dalle, S
Haydon, AM
Meshcheryakov, A
Khattak, A
Carlino, MS
Sandhu, S
Larkin, J
Puig, S
Ascierto, PA
Rutkowski, P
Schadendorf, D
Koornstra, R
Hernandez-Aya, L
Di Giacomo, AM
van den Eertwegh, AJM
Grob, J-J
Gutzmer, R
Jamal, R
Lorigan, PC
van Akkooi, ACJ
Krepler, C
Ibrahim, N
Marreaud, S
Kicinski, M
Suciu, S
Robert, C

November 2020

Purpose We conducted the phase III double-blind European Organisation for Research and Treatment of ...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M. M.
Blank, Christian U.
Mandala, Mario
Long, Georgina V.
Atkinson, Victoria G.
Dalle, Stéphane
Haydon, Andrew M.
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S.
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A.
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J. M.
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C.
van Akkooi, Alexander C. J.
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

November 2020

PURPOSE We conducted the phase III double-blind European Organisation for Research and Treatment of ...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, AMM
Blank, CU
Mandala, M
Long, GV
Atkinson, VG
Dalle, S
Haydon, AM
Meshcheryakov, A
Khattak, A
Carlino, MS
Sandhu, S
Larkin, J
Puig, S
Ascierto, PA
Rutkowski, P
Schadendorf, D
Koornstra, R
Hernandez-Aya, L
Di Giacomo, AM
van den Eertwegh, AJM
Grob, J-J
Gutzmer, R
Jamal, R
Lorigan, PC
van Akkooi, ACJ
Krepler, C
Ibrahim, N
Marreaud, S
Kicinski, M
Suciu, S
Robert, C

November 2020

PURPOSE: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M M
Blank, Christian U
Mandala, Mario
Long, Georgina V
Atkinson, Victoria G
Dalle, Stéphane
Haydon, Andrew M
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J M
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C
van Akkooi, Alexander C J
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

January 2020

Purpose: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M M
Blank, Christian U
Mandala, Mario
Long, Georgina V
Atkinson, Victoria G
Dalle, Stéphane
Haydon, Andrew M
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J M
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C
van Akkooi, Alexander C J
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

January 2020

Purpose: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M M
Blank, Christian U
Mandala, Mario
Long, Georgina V
Atkinson, Victoria G
Dalle, Stéphane
Haydon, Andrew M
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J M
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C
van Akkooi, Alexander C J
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

January 2020

Purpose: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: Updated results from the EORTC 1325-MG/KEYNOTE-054 trial

Eggermont, Alexander M. M.
Blank, Christian U.
Mandala, Mario
Long, Georgina V.
Atkinson, Victoria G.
Dalle, Stéphane
Haydon, Andrew M.
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S.
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A.
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J. M.
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C.
van Akkooi, Alexander C. J.
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine

January 2020

PURPOSE: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: Updated results from the EORTC 1325-MG/KEYNOTE-054 trial

Eggermont, Alexander M. M.
Blank, Christian U.
Mandala, Mario
Long, Georgina V.
Atkinson, Victoria G.
Dalle, Stéphane
Haydon, Andrew M.
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S.
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A.
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J. M.
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C.
van Akkooi, Alexander C. J.
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine

January 2020

PURPOSE: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont A. M. M.
Blank C. U.
Mandala M.
Long G. V.
Atkinson V. G.
Dalle S.
Haydon A. M.
Meshcheryakov A.
Khattak A.
Carlino M. S.
Sandhu S.
Larkin J.
Puig S.
Ascierto P. A.
Rutkowski P.
Schadendorf D.
Koornstra R.
Hernandez-Aya L.
Di Giacomo A. M.
van den Eertwegh A. J. M.
Grob J. -J.
Gutzmer R.
Jamal R.
Lorigan P. C.
van Akkooi A. C. J.
Krepler C.
Ibrahim N.
Marreaud S.
Kicinski M.
Suciu S.
Robert C.
Menzies A.
Lesimple T.
Maio M.
Linette G.
Brown M.
Hersey P.
Svane I. M.
Mortier L.
Schachter J.
Barrow C.
Kudchadkar R.
Song X.
Dutriaux C.
Quaglino P.
Meier F.
Queirolo P.
Stroyakovskiy D.
Bastholt L.
Guillot B.
Garbe C.
Ortiz Romero P. L.
Grange F.
Mohr P.
Algazi A.
Bechter O.
Hernberg M.
Arnault J. -P.
Saiag P.
Loquai C.
Meiss F.
Simon J. -C.
Bar-Sela G.
Chiarion Sileni V.
Fitzharris B.
McCrystal M.
Parente P.
Baurain J. -F.
Combemale P.
Lebbe C.
Hauschild A.
Yamazaki N.
Dummer R.
Milhem M.
Dzienis M.
Walker J.
Geoffrois L.
Leccia M. -T.
Kretschmer L.
Hendler D.
Lotem M.
Mackiewicz A.
Sekulovic L.
Dunwoodie E.
Hoeller C.
Machet L.
Hassel J.
Hospers G. A. P.
Passos M. -J.
Levin M.
Fehr M.
Corrie P.
Waterston A.
Hallmeyer S.
Schmidt H.
Descamps V.
Lacour J. -P.
Berking C.
Kiecker F.
Ferrucci P. F.
Yokota K.
Aarts M.
Jameson M.
Winge-Main A. K.
Ferreira P.
Kim K.
McNeil C.
Hofmann-Wellenhof R.
Kerger J.
Aubin F.
Utikal J.
Ferraresi V.
Inozume T.
Kiyohara Y.
Groenewegen G.
Kapiteijn H.
Matkovic S.
Boehncke W. -H.
Casasola R.
Crook T.
Marshall E.
Skytta T.
Avril M. -F.
Jouary T.
Hein R.
Terheyden P.
Aoi J.
Takenouchi T.
Straume O.
Martins C.
Mukhametshina G.
Nathan P.

January 2021

Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 ...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

May 2021

Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 ...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander M M
Blank, Christian U
Mandalà, Mario
Long, Georgina V
Atkinson, Victoria G
et al
Dummer, Reinhard

May 2021

BACKGROUND The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-05...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.

Eggermont, AMM
Blank, CU
Mandala, M
Long, GV
Atkinson, VG
Dalle, S
Haydon, AM
Meshcheryakov, A
Khattak, A
Carlino, MS
Sandhu, S
Larkin, J
Puig, S
Ascierto, PA
Rutkowski, P
Schadendorf, D
Koornstra, R
Hernandez-Aya, L
Di Giacomo, AM
van den Eertwegh, AJM
Grob, J-J
Gutzmer, R
Jamal, R
Lorigan, PC
van Akkooi, ACJ
Krepler, C
Ibrahim, N
Marreaud, S
Kicinski, M
Suciu, S
Robert, C

November 2020

Purpose We conducted the phase III double-blind European Organisation for Research and Treatment of ...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M. M.
Blank, Christian U.
Mandala, Mario
Long, Georgina V.
Atkinson, Victoria G.
Dalle, Stéphane
Haydon, Andrew M.
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S.
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A.
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J. M.
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C.
van Akkooi, Alexander C. J.
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

November 2020

PURPOSE We conducted the phase III double-blind European Organisation for Research and Treatment of ...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, AMM
Blank, CU
Mandala, M
Long, GV
Atkinson, VG
Dalle, S
Haydon, AM
Meshcheryakov, A
Khattak, A
Carlino, MS
Sandhu, S
Larkin, J
Puig, S
Ascierto, PA
Rutkowski, P
Schadendorf, D
Koornstra, R
Hernandez-Aya, L
Di Giacomo, AM
van den Eertwegh, AJM
Grob, J-J
Gutzmer, R
Jamal, R
Lorigan, PC
van Akkooi, ACJ
Krepler, C
Ibrahim, N
Marreaud, S
Kicinski, M
Suciu, S
Robert, C

November 2020

PURPOSE: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M M
Blank, Christian U
Mandala, Mario
Long, Georgina V
Atkinson, Victoria G
Dalle, Stéphane
Haydon, Andrew M
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J M
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C
van Akkooi, Alexander C J
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

January 2020

Purpose: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M M
Blank, Christian U
Mandala, Mario
Long, Georgina V
Atkinson, Victoria G
Dalle, Stéphane
Haydon, Andrew M
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J M
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C
van Akkooi, Alexander C J
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

January 2020

Purpose: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Eggermont, Alexander M M
Blank, Christian U
Mandala, Mario
Long, Georgina V
Atkinson, Victoria G
Dalle, Stéphane
Haydon, Andrew M
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J M
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C
van Akkooi, Alexander C J
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline

January 2020

Purpose: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: Updated results from the EORTC 1325-MG/KEYNOTE-054 trial

Eggermont, Alexander M. M.
Blank, Christian U.
Mandala, Mario
Long, Georgina V.
Atkinson, Victoria G.
Dalle, Stéphane
Haydon, Andrew M.
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S.
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A.
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J. M.
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C.
van Akkooi, Alexander C. J.
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine

January 2020

PURPOSE: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: Updated results from the EORTC 1325-MG/KEYNOTE-054 trial

Eggermont, Alexander M. M.
Blank, Christian U.
Mandala, Mario
Long, Georgina V.
Atkinson, Victoria G.
Dalle, Stéphane
Haydon, Andrew M.
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo S.
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo A.
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus J. M.
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul C.
van Akkooi, Alexander C. J.
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine

January 2020

PURPOSE: We conducted the phase III double-blind European Organisation for Research and Treatment of...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont A. M. M.
Blank C. U.
Mandala M.
Long G. V.
Atkinson V. G.
Dalle S.
Haydon A. M.
Meshcheryakov A.
Khattak A.
Carlino M. S.
Sandhu S.
Larkin J.
Puig S.
Ascierto P. A.
Rutkowski P.
Schadendorf D.
Koornstra R.
Hernandez-Aya L.
Di Giacomo A. M.
van den Eertwegh A. J. M.
Grob J. -J.
Gutzmer R.
Jamal R.
Lorigan P. C.
van Akkooi A. C. J.
Krepler C.
Ibrahim N.
Marreaud S.
Kicinski M.
Suciu S.
Robert C.
Menzies A.
Lesimple T.
Maio M.
Linette G.
Brown M.
Hersey P.
Svane I. M.
Mortier L.
Schachter J.
Barrow C.
Kudchadkar R.
Song X.
Dutriaux C.
Quaglino P.
Meier F.
Queirolo P.
Stroyakovskiy D.
Bastholt L.
Guillot B.
Garbe C.
Ortiz Romero P. L.
Grange F.
Mohr P.
Algazi A.
Bechter O.
Hernberg M.
Arnault J. -P.
Saiag P.
Loquai C.
Meiss F.
Simon J. -C.
Bar-Sela G.
Chiarion Sileni V.
Fitzharris B.
McCrystal M.
Parente P.
Baurain J. -F.
Combemale P.
Lebbe C.
Hauschild A.
Yamazaki N.
Dummer R.
Milhem M.
Dzienis M.
Walker J.
Geoffrois L.
Leccia M. -T.
Kretschmer L.
Hendler D.
Lotem M.
Mackiewicz A.
Sekulovic L.
Dunwoodie E.
Hoeller C.
Machet L.
Hassel J.
Hospers G. A. P.
Passos M. -J.
Levin M.
Fehr M.
Corrie P.
Waterston A.
Hallmeyer S.
Schmidt H.
Descamps V.
Lacour J. -P.
Berking C.
Kiecker F.
Ferrucci P. F.
Yokota K.
Aarts M.
Jameson M.
Winge-Main A. K.
Ferreira P.
Kim K.
McNeil C.
Hofmann-Wellenhof R.
Kerger J.
Aubin F.
Utikal J.
Ferraresi V.
Inozume T.
Kiyohara Y.
Groenewegen G.
Kapiteijn H.
Matkovic S.
Boehncke W. -H.
Casasola R.
Crook T.
Marshall E.
Skytta T.
Avril M. -F.
Jouary T.
Hein R.
Terheyden P.
Aoi J.
Takenouchi T.
Straume O.
Martins C.
Mukhametshina G.
Nathan P.

January 2021

Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 ...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander
Blank, Christian,
Mandalà, Mario
Long, Georgina
Atkinson, Victoria,
Dalle, Stéphane
Haydon, Andrew
Meshcheryakov, Andrey
Khattak, Adnan
Carlino, Matteo
Sandhu, Shahneen
Larkin, James
Puig, Susana
Ascierto, Paolo,
Rutkowski, Piotr
Schadendorf, Dirk
Koornstra, Rutger
Hernandez-Aya, Leonel
Di Giacomo, Anna Maria
van den Eertwegh, Alfonsus
Grob, Jean-Jacques
Gutzmer, Ralf
Jamal, Rahima
Lorigan, Paul
van Akkooi, Alexander
Krepler, Clemens
Ibrahim, Nageatte
Marreaud, Sandrine
Kicinski, Michal
Suciu, Stefan
Robert, Caroline
Menzies, Alex
Lesimple, Thierry
Maio, Michele
Linette, Gerald
Brown, Michael
Hersey, Peter
Svane, Inge Marie
Mortier, Laurent
Schachter, Jacob
Barrow, Catherine
Kudchadkar, Ragini
Song, Xinni
Dutriaux, Caroline
Quaglino, Pietro
Meier, Friedegund
Queirolo, Paola
Stroyakovskiy, Daniil
Bastholt, Lars
Guillot, Bernard
Garbe, Claus
Ortiz Romero, Pablo Luis
Grange, Florent
Mohr, Peter
Algazi, Alain
Bechter, Oliver
Hernberg, Micaela
Arnault, Jean-Philippe
Saiag, Philippe
Loquai, Carmen
Meiss, Frank
Simon, Jan-Christoph
Bar-Sela, Gil
Chiarion Sileni, Vanna
Fitzharris, Bernard
Mccrystal, Mike
Parente, Phillip
Baurain, Jean-Francois
Combemale, Patrick
Lebbe, Célèste
Hauschild, Axel
Yamazaki, Naoya
Dummer, Reinhard
Milhem, Mohammed
Dzienis, Marcin
Walker, John
Geoffrois, Lionel
Leccia, Marie-Thérèse
Kretschmer, Lutz
Hendler, Daniel
Lotem, Michal
Mackiewicz, Andrzej
Sekulovic, Lidija
Dunwoodie, Elaine
Hoeller, Christoph
Machet, Laurent
Hassel, Jessica
Hospers, Geke A.P.
Passos, Maria-Jose
Levin, Max
Fehr, Martin
Corrie, Philippa
Waterston, Ashita
Hallmeyer, Sigrun
Schmidt, Henrik
Descamps, Vincent
Lacour, Jean-Philippe
Berking, Carola
Kiecker, Felix
Ferrucci, Pier Francesco
Yokota, Kenji
Aarts, Maureen
Jameson, Michael
Winge-Main, Anna Katharina
Ferreira, Paula
Kim, Kevin
Mcneil, Catriona
Hofmann-Wellenhof, Reiner
Kerger, Joseph
Aubin, François
Utikal, Jochen
Ferraresi, Virginia
Inozume, Takashi
Kiyohara, Yoshio
Groenewegen, Gerard
Kapiteijn, Helena
Matkovic, Suzana
Boehncke, Wolf-Henning
Casasola, Richard
Crook, Timothy
Marshall, Ernest
Skytta, Tanja
Avril, Marie-Francoise
Jouary, Thomas
Hein, Rüdiger
Terheyden, Patrick
Aoi, Jun
Takenouchi, Tatsuya
Straume, Oddbjorn
Martins, César
Mukhametshina, Guzel
Nathan, Paul

May 2021

International audienceBackground: The European Organisation for Research and Treatment of Cancer (EO...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

May 2021

Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 ...

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Eggermont, Alexander M M
Blank, Christian U
Mandalà, Mario
Long, Georgina V
Atkinson, Victoria G
et al
Dummer, Reinhard

May 2021

BACKGROUND The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-05...

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Abstract

Extracted data

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Abstract

Extracted data

Related items

Related items